Patent: 7,465,434
✉ Email this page to a colleague
Summary for Patent: 7,465,434
| Title: | Diagnosis of blood clots using fibrin-binding proteins bound with contrast agents |
| Abstract: | This invention describes how to modify a fibrin-binding protein, such as tPA, with a contrast agent, such as iodine. This substance could then be given to a patient suspected of having a blood clot by an intravenous route, and then detected by a radiographic study at a short pre-determined time later. Appropriate therapy is started immediately as determined by the radiographic study. |
| Inventor(s): | Benford; Jacob (Palo Alto, CA) |
| Assignee: | |
| Application Number: | 11/411,256 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,465,434
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | ACTIVASE | alteplase | For Injection | 103172 | 11/13/1987 | ⤷ Try a Trial | 2025-04-25 |
| Genentech, Inc. | CATHFLO ACTIVASE | alteplase | For Injection | 103172 | 09/04/2001 | ⤷ Try a Trial | 2025-04-25 |
| Chiesi Usa, Inc. | RETAVASE | reteplase | For Injection | 103786 | 10/30/1996 | ⤷ Try a Trial | 2025-04-25 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
